Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 410 participants.

Also called NCT07824492

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 410 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07824492
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07824492. Randomized; no masking; primary purpose prevention. Start 2026-10-01 (anticipated); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB
Acronym
TRAP-AF
Condition
Atrial Fibrillation (AF)
Condition
OPCABG
Intervention (Device)
Transcutaneous Auricular Vagus Nerve Stimulation
Lead sponsor
Ruijin Hospital (class: other)

Record details

Record id
cardio:ct-nct07824492
Content hash
d340a94cb2dc44665f9e4036c67be80647b276a8f95e513bfc3e79ae28d2e4fc